Dallah Healthcare
دله الصحيةTechnical Analysis & Signals
Dallah Healthcare closed at SAR 58.7, down 0.25%. RSI at 33.1 in neutral zone. Current signal: Hold.
Technical Analysis
Dallah Healthcare closed at SAR 58.7, below the 50-day SMA (70.45 SAR). RSI at 33.1 (neutral). MACD shows bullish momentum with histogram at 0.4438. Bollinger range: 55.13 – 66.67 SAR.
Support & Resistance Levels
Key support at SAR 54.63. Resistance at SAR 86.95. A break below support could push the stock toward SAR 52.99, while a breakout above resistance opens the path to SAR 89.56.
Volume Analysis
Session volume 47,294 shares is below the 30-day average (259,817 shares). Lower volume may indicate a wait-and-see market stance.
Fundamental Factors
P/E ratio at 16.3x. Dividend yield around 2.48%, attractive for income investors. Market cap SAR 7,154,926,592.0.
Risk Factors
Stock is down 51.2% from its 52-week high. Trading in oversold territory (RSI 33) may offer buying opportunities but carries downside risk.
Recommendation
Based on current technical and fundamental data for Dallah Healthcare. Monitor support at SAR 54.63 and resistance at SAR 86.95 for entry and exit points.
Financial Fundamentals
Price Data
Price Chart - Dallah Healthcare
4004Technical Analysis
Moving Averages
Momentum Indicators
Bollinger Bands
Within BandTrend Strength (ADX)
Strong TrendFinancial Summary
Valuation
- Market Cap
- 7.15B
- P/E Ratio
- 16.30
- P/B Ratio
- 1.60
- EPS (Earnings/Share)
- 3.61
Profitability
- Revenue
- 4.32B
- Net Income
- 737.16M
- Return on Equity (ROE)
- +16.30%
- Shares Outstanding
- 121.89M
Balance Sheet
- Total Assets
- 9.14B
- Total Debt
- 3.97B
- Debt/Equity
- 0.88
- Free Float %
- +42.5%
Dividends & Margins
- Dividend Yield
- +3.40%
- Dividend/Share
- 2.00
- Book Value
- 36.69
Financial data extracted from published quarterly reports. All values in SAR unless otherwise stated.
Historical Financial Data
5 years| Year | Revenue | Net Income | Total Assets | Total Debt | EPS |
|---|---|---|---|---|---|
| 2025 | 4.07B +26.9% | 538.27M +14.2% | 9.14B +38.2% | 3.93B +94.5% | 4.42 +14.2% |
| 2024 | 3.21B +8.9% | 471.20M +30.8% | 6.61B +5.9% | 2.02B +2.5% | 3.87 +31.2% |
| 2023 | 2.94B +18.3% | 360.12M +31.2% | 6.24B +26.9% | 1.97B -0.2% | 2.95 +31.1% |
| 2022 | 2.49B | 274.46M | 4.92B | 1.98B | 2.25 |
| 2021 | — | — | — | — | — |
Historical data sourced from Yahoo Finance and may differ from official audited financial reports.
Price Forecast
These forecasts are based on technical analysis and AI and do not constitute investment advice. Past performance does not guarantee future results.
News & Events
No news currently available for Dallah Healthcare
Sector Comparison
| Symbol | Name | Price | Change% |
|---|---|---|---|
| 4013 | Dr. Sulaiman Al Habib | 212.10 SAR | |
| 4002 | Mouwasat | 58.45 SAR | |
| 4004 | Dallah Healthcare | 58.70 SAR | |
| 4017 | Fakeeh Care | 30.00 SAR | |
| 4005 | CARE | 114.00 SAR | |
| 4018 | Almoosa | 110.80 SAR | |
| 4007 | Alhammadi | 21.95 SAR | |
| 4019 | SMC Healthcare | 12.60 SAR |
Dividend History
Dividend data from Tadawul records. All amounts in SAR. Estimated yield calculated based on year-end price.
Ownership Structure
Data source: Yahoo FinanceLast updated: 2026-11-17
Risk Assessment
Risk Factors
Average True Range 3.6% of stock price
Trading volume below 30% of average
P/E ratio 16.3
Debt-to-equity ratio 0.88
ADX indicator at 46 — clear trend direction
High volatility and financial pressures requiring careful monitoring
This assessment is automated based on quantitative data and does not constitute investment advice. Please consult a licensed financial advisor before making investment decisions.
FAQ
1 What is Dallah Healthcare stock price today?
Dallah Healthcare (4004) stock price today is 58.70 SAR, declining by -0.25% compared to the previous session close. The 52-week price range is between 54.63 SAR and 120.38 SAR.
2 What is Dallah Healthcare stock valuation?
The automated analysis signal for Dallah Healthcare is "Hold" with 50% confidence. The P/E ratio is 16.3. The P/B ratio is 1.60.
3 Is Dallah Healthcare Shariah-compliant?
Yes, Dallah Healthcare (4004) is Shariah-compliant according to the latest lists approved by relevant Shariah authorities.
4 What are Dallah Healthcare dividend distributions?
Dallah Healthcare has a dividend yield of 3.40%, with an estimated annual dividend of 2.00 SAR per share.
5 What is Dallah Healthcare weekly performance?
Dallah Healthcare performance over different time periods: weekly change +1.21%, monthly -16.79%, and year-to-date -42.48%. The stock is currently trading with a volume of 47,294 shares.
6 What is the target level for Dallah Healthcare?
According to automated analysis for Dallah Healthcare: Short-term target (1-2 weeks): 60.46 SAR. Medium-term target (1-3 months): 63.40 SAR. Support level: 54.63 SAR. Resistance level: 86.95 SAR. Note: These are automated analytical levels and do not constitute investment advice.
Disclaimer
The information provided on this page is for educational and analytical purposes only and does not constitute investment advice or a recommendation to buy or sell. Past performance does not guarantee future results. All investments involve risk including loss of capital. Please consult a licensed financial advisor before making any investment decisions.
Automated analysis relies on historical data and technical indicators and may not reflect future market conditions.